The forecast for Germany's sold production of medicaments of other antibiotics packaged for retail sale displays a gradual decline from 2024 to 2028, with the value decreasing from 2.453 billion to 2.4245 billion euros. Starting from a potential estimate of around 2.46 billion euros in 2023, the year-on-year percentage change shows a modest shrinking trend around 0.3% annually. The five-year compound annual growth rate (CAGR) reflects this steady decline underlining potential adjustments in market demand or production efficiencies.
Future trends to watch for include the impact of regulatory changes, potential shifts in healthcare policies, advancements in antibiotic alternatives, and evolving consumer preferences towards generic products. Keeping an eye on global market dynamics and pharmaceutical innovations may also influence these forecasts.
